Evidence map›Paper›PMID 42327836›Full record

ArticleClinical and translational radiation oncology2026

Corrigendum to "Mini-GRID enhances survival and reduces toxicity in an orthotopic murine model of oral squamous cell carcinoma: A proof-of-concept study". [Clin. Trans. Rad. Oncol. 57 (2026) 101101].

Loris Roncali, Maria Isabel Acuña-Perez, Julie Espenon, Manuel Sánchez-García, Victor Luna-Vega, Eva G Kölmel, Cristèle Gilbert, Mathieu Sertorio, Marjorie Juchaux, Yolanda Prezado

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Loris RoncaliNew Approaches in Radiotherapy Lab, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), University of Santiago de Compostela E-15782 Santiago de Compostela, Spain.
Maria Isabel Acuña-PerezNew Approaches in Radiotherapy Lab, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), University of Santiago de Compostela E-15782 Santiago de Compostela, Spain.
Julie EspenonCurie Institute, PSL University, CNRS UMR3347, Inserm U1021, Radiobiology and Cancer Signaling, F-91400 Orsay, France.
Manuel Sánchez-GarcíaDepartment of Radiophysics and Radiological Protection, University Hospital of Santiago de Compostela E-15782 Santiago de Compostela, Spain.
Victor Luna-VegaDepartment of Radiophysics and Radiological Protection, University Hospital of Santiago de Compostela E-15782 Santiago de Compostela, Spain.
Eva G KölmelDepartment of Radiophysics and Radiological Protection, University Hospital of Santiago de Compostela E-15782 Santiago de Compostela, Spain.
Cristèle GilbertCurie Institute, PSL University, CNRS UMR3347, Inserm U1021, Radiobiology and Cancer Signaling, F-91400 Orsay, France.
Mathieu SertorioDepartment of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, OH 45221, USA.
Marjorie JuchauxCurie Institute, PSL University, CNRS UMR3347, Inserm U1021, Radiobiology and Cancer Signaling, F-91400 Orsay, France.
Yolanda PrezadoNew Approaches in Radiotherapy Lab, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), University of Santiago de Compostela E-15782 Santiago de Compostela, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.ctro.2025.101101.].

Identifiers

PMID42327836
PMCPMC13280437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.